Vimarsana.com

Latest Breaking News On - Biocryst pharmaceuticals - Page 1 : vimarsana.com

Oracle Investment Management Inc. Sells 19,964 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Oracle Investment Management Inc. reduced its holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 535,558 shares of the biotechnology company’s stock after selling 19,964 shares during the period. […]

Alang-levin
Stevenk-galson
Exchange-commission
Securities-exchange-commission
News-ratings-for-biocryst-pharmaceuticals-daily
Quarter-for-biocryst-pharmaceuticals
Deerfield-management-companylp-series
Vanguard-group-inc
Nasdaq
Needham-company
Oracle-investment-management-inc

Avoro Capital Advisors LLC Increases Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Avoro Capital Advisors LLC lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,050,000 shares of the biotechnology company’s stock after purchasing an additional 1,500,000 shares during […]

Recursos-ltda
Stevenk-galson
Nancyj-hutson
Quarter-for-biocryst-pharmaceuticals
Exchange-commission
Nasdaq
Pinnacle-wealth-planning-services-inc
Avoro-capital-advisors
Biocryst-pharmaceuticals-inc
News-ratings-for-biocryst-pharmaceuticals-daily
Biocryst-pharmaceuticals
Securities-exchange-commission

Avoro Capital Advisors LLC Increases Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

Avoro Capital Advisors LLC lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,050,000 shares of the biotechnology company’s stock after purchasing an additional 1,500,000 shares during […]

Recursos-ltda
Nancyj-hutson
Stevenk-galson
Biocryst-pharmaceuticals
Biocryst-pharmaceuticals-stock-performance
Securities-exchange-commission
Biocryst-pharmaceuticals-company-profile
Needham-company
Capstone-investment-advisors
Tower-research-capital
Quarter-for-biocryst-pharmaceuticals
Pinnacle-wealth-planning-services-inc

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Director Buys $49,995.96 in Stock

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Director Buys $49,995.96 in Stock
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Alang-levin
Recursos-ltda
Biocryst-pharmaceuticals-inc
News-ratings-for-biocryst-pharmaceuticals-daily
Tower-research-capital
Biocryst-pharmaceuticals-trading-down
Securities-exchange-commission
Institutional-trading-of-biocryst-pharmaceuticals
Nasdaq
Biocryst-pharmaceuticals
Needham-company
Get-free-report

vimarsana © 2020. All Rights Reserved.